Medicare drug wars

The proposed federal policy rule that would make major changes to Medicare Advantage and the Medicare Part D drug program is being blasted by both health insurers and pharmacy benefit managers. One of the most controversial suggestions would mandate a certain amount of drug company rebates be applied to what people pay at the point of sale at pharmacies. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or


Leave a Reply